Treatment Decisions in Multiple Myeloma
New England Journal of Medicine · 10.09.2026 · 395 (10) · 992-1008
DOI: 10.1056/nejmra2605253 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift New England Journal of Medicine, erschienen am 10.09.2026. Verfasst von Tarek H Mouhieddine und 1 weiteren Autor:innen. Beteiligte Einrichtung: Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston. Hauptthemen laut MEDLINE: Clinical Decision-Making, Multiple Myeloma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 124 Literaturangaben.
Abstract (Originalsprache)
Revolutions in transplantation and targeted and immune therapies have transformed multiple myeloma from a disease with an associated survival of a few years into one for which functional cure is an emerging goal. This abundance of effective therapies has created clinical complexity. Here we provide a practical framework, anchored in trial evidence and informed by emerging biologic discoveries, for the navigation of treatment decisions across the disease spectrum. We outline how cytogenetic and genomic risk stratification, functional fitness, and measurable residual disease status individualize therapy in newly diagnosed disease, in which quadruplet induction therapy is now standard and the role of autologous transplantation is being reevaluated. Regarding relapse, we address the sequencing of B-cell maturation antigen-directed chimeric antigen receptor (CAR) T cells, bispecific antibodies, and antibody-drug conjugates, emphasizing T-cell fitness and multiantigen targeting to counter exhaustion and antigen escape. We also consider early interception in high-risk smoldering myeloma. Throughout, we underscore that enrollment of patients in clinical trials should be considered in order to ensure continued progress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston.
ORCID-Profile: Tarek H Mouhieddine
Zitieren
APA
Mouhieddine, T. H., & Anderson, K. C. (2026). Treatment Decisions in Multiple Myeloma. New England Journal of Medicine, 395(10), 992-1008. https://doi.org/10.1056/nejmra2605253
Vancouver
Mouhieddine TH, Anderson KC. Treatment Decisions in Multiple Myeloma. New England Journal of Medicine. 2026;395(10):992-1008. doi:10.1056/nejmra2605253
BibTeX
@article{Mouhieddine2026,
author = {Mouhieddine, Tarek H and Anderson, Kenneth C},
title = {Treatment Decisions in Multiple Myeloma},
journal = {New England Journal of Medicine},
year = {2026},
volume = {395},
number = {10},
pages = {992--1008},
doi = {10.1056/nejmra2605253}
}
EUVIMED